Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and

Andreas Edsfeldt1, Isabel Gonçalves2, Isa Vigren3

  • 1Department of Clinical Sciences Malmö, Lund University, Sweden; Department of Cardiology, Skåne University Hospital, Sweden; Wallenberg Center for Molecular Medicine, Lund University, Sweden.

Vascular Pharmacology
|August 27, 2023
PubMed

Insights

High levels of Interleukin-6 (IL-6) are linked to increased cardiovascular disease (CVD) risk and atherosclerosis. Soluble IL-6 receptor (sIL-6R) is not a reliable CVD risk marker but reflects plaque inflammation.

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiovascular Medicine

Background:

  • Residual cardiovascular disease (CVD) risk is linked to persistent vascular inflammation.
  • Interleukin-6 (IL-6) is a key mediator of inflammation and a potential therapeutic target.
  • IL-6 exerts its effects through direct receptor binding or via soluble IL-6 receptors (sIL-6R).

Purpose of the Study:

  • To investigate the association between IL-6 and sIL-6R pathways and the risk of cardiovascular disease (CVD).
  • To evaluate the relationship between IL-6/sIL-6R and atherosclerosis, arterial stiffness, and endothelial function.
  • To determine the role of sIL-6R in plaque inflammation.

Main Methods:

  • Analysis of IL-6 and sIL-6R in plasma samples from three large prospective cohorts (MDC, SUMMIT VIP, CPIP) using proximity extension assay.
  • Longitudinal follow-up for incident cardiovascular events (myocardial infarction) and assessment of clinical outcomes.
  • Immunohistochemistry and biochemical analysis of atherosclerotic plaques.

Main Results:

  • Elevated plasma IL-6 levels were significantly associated with an increased risk of myocardial infarction (HR 2.60 [2.08-3.25]).
  • High IL-6 correlated with increased atherosclerosis, arterial stiffness, and impaired endothelial function.
  • Soluble IL-6 receptor (sIL-6R) showed no independent association with CVD risk or vascular function but was linked to plaque inflammation.

Conclusions:

  • Plasma IL-6 is a significant risk marker for cardiovascular events and associated vascular pathologies.
  • Soluble IL-6 receptor (sIL-6R) is not a reliable indicator of overall CVD risk.
  • The association of sIL-6R with plaque inflammation suggests a complex role for IL-6 signaling in atherosclerosis.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
53.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K